Multiple Complete Responses in a Phase 1 Dose-Escalation Study of the Antibody-Drug Conjugate SGN-35 in Patients with Relapsed or Refractory CD30-Positive Lymphomas.
- Resource Type
- Abstract
- Source
- In
Blood 16 November 2008 112(11):1006-1006 - Subject
- Language
- ISSN
- 0006-4971